Psoriasis: Characteristics, psychosocial effects and treatment options

British Journal of Nursing

Volumn 19, Issue 13, 2010, Pages 820-825

  Ryan, Sheila ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Dermatology; Psoriasis; Psychosocial consequences; Treatments

Indexed keywords

DERMATOLOGICAL AGENT;

ARTICLE; HUMAN; NURSING; PATHOLOGY; PHOTOTHERAPY; PSORIASIS; PSYCHOLOGICAL ASPECT; SOCIAL ISOLATION;

DERMATOLOGIC AGENTS; HUMANS; PHOTOTHERAPY; PSORIASIS; SOCIAL ISOLATION;

EID: 77955879652     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2010.19.13.48856     Document Type: Article

References (30)

1. Barker J (2001) Genetic aspects of psoriasis. Clin Exp Dermatol 26(4): 321-325
2. British Association of Dermatologists (2006) Psoriasis Guidelines. BAD, London
3. British Photodermatology Group (1994) British Photodermatology Group guidelines for PUVA. Br J Dermatol 130(2): 246-255
4. Duffy DL, Spelman LS, Martin NG (1993) Psoriasis in Australian twins. J Am Acad Dermatol 29(3): 428-434
5. Elder JT, Heneseler T, Christophers E, Voorhees JJ, Nair RP (1994) Of genes and antigens: the inheritance of psoriasis. J Invest Dermatol 103(5): 150S-53S
6. Electronic Medicines Compendium (2008) Summary of product characteristics: Adaliumab/Infliximab/Etanercept/Efalizumab. http://emc.medicines.org.uk (accessed 1 July2010)
7. Farber EM, Nall ML, Watson W (1974) Natural history of psoriasis in 61 twin pairs. Arch Dermatol 109(2): 207-211
8. Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 19(3): 210-216
9. Fitzpatrick TB, Allen Johnson R, Wolff K, Suurmond D (2001) Color Atlas and Synopsis of Clinical Dermatology. McGraw-Hill, New York
10. Fortune DG, Richards AL, Main CJ, Griffiths CE (1998) What patients with psoriasis believe about their condition. J Am Acad Dermatol 39(2): 196-201
11. Griffiths CEM, Camp RDR, Barker JNWN (2004) Psoriasis. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology. 7th edn. Blackwell Science, Massachusetts: 1-35, 69
12. Griffiths CEM, Taylor H, Collins SI et al (2006) The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial. Br J Dermatol 155(2): 393-400
13. Gupta MA, Gupta AK (1997) Psoriasis and sex! A study of moderately to severely affected patients. Int J Dermatol 36(4): 259-262
14. Habif TP, Campbell JL, Shane Chapman M, Dinulos JGH, Zug KA (2006) Dermatology. Mosby Elsevier, Philadelphia
15. Hunter JAA, Savin JA, Dahl MV (1995) Clinical Dermatology. Blackwell Science, Oxford
16. Jackson K, Maguire S, Reid F, Rowe A, Waite A (2007) Biologic therapies in psoriasis: the key role of the Dermatology Nurse Specialist. Dermatol Nurs 6(1): Suppl 1-11
17. Joint Formulary Committee (2010) British National Formulary 59. March BMJ Publishing Group Ltd and RPS Publishing, London
18. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T (2001) The impact of psoriasis on quality of life. Arch Dermatol 137(3): 280-284
19. Lomholt G (1963) Psoriasis. Prevalence, Spontaneous Course and Genetics. A Census Study on the Prevalence of Skin Disease on the Faroe Islands. GEC Gad, Copenhagen
20. National Institute for Health and Clinical Excellence (2006) Etanercept and Efalizumab for the Treatment of Adults with Psoriasiss. http://tinyurl.com/ 3yuy4w (accessed 1 July2010)
21. National Institute for Health and Clinical Excellence (2008) Infliximab for the Treatment of Psoriasis. http://tinyurl.com/2zgdmw (accessed 1 July 2010)
22. Mason J, Mason AR, Cork MJ (2002) Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol 146(3): 351-364
23. Peters J (2005) Exploring the use of emollient therapy in dermatological nursing. Br J Nurs 14(9): 494-502
24. Peters BP, Weissman FG, Gill MA (2000) Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm 57(7): 645-659
25. Ramsay B, O'Reagan M (1988) A survey of the social and psychological effects of psoriasis. Br J Dermatol 118(1): 195-201
26. Rapp SR, Feldman SR, Exum ML, Fleisher AB, Reboussin DM (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41(3): 401-407
27. Smith CH, Anstey AV, Barker JNWN et al (2005) British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Derm 153(3): 486-497
28. Van Onselen J (1998) Psoriasis in general practice. Nurs Stand 12(30): 32-33
29. Van Onselen J (2001) Psoriasis. In: Hughes E, Van Onselen J, eds. Dermatology Nursing: A Practical Guide. Churchill Livingstone, Edinburgh: 133-149
30. Wakelin SH (2002) Handbook of Systemic Drug Treatment in Dermatology. Manson Publishing, London